Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution

Shamiya Sadiq; Sapna Gupta; Vijay Khajuria; Vishal R Tandon; Annil Mahajan; Mrityunjay Gupta

doi:10.5455/njppp.2016.6.31012016114

2022, Vol: 12, Issue: 6

12/6Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Natl J Physiol Pharm Pharmacol. 2016; 6(3): 205-208

doi: 10.5455/njppp.2016.6.31012016114

Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution

Shamiya Sadiq, Sapna Gupta, Vijay Khajuria, Vishal R Tandon, Annil Mahajan, Mrityunjay Gupta.

Cited by (2)

Abstract
Background: The introduction of highly active antiretroviral therapy (HAART) has led to significant reduction in acquired immune deficiency syndrome (AIDS) related to morbidity and mortality. However, adverse drug reactions (ADRs) to antiretroviral treatment (ART) are major obstacles.

Aims and Objective: To examine the adverse effects of antiretroviral therapy in a tertiary care hospital.

Materials and Methods: Ninety patients receiving antiretroviral therapy were studied prospectively over a period of 6 months and were evaluated for ADRs.

Result: Of the 90 patients, 80 (89%) developed ADRs. A total of 111 ADR events were seen in 80 patients. The number of adverse drug events was seen higher in females (64%) than males (36%). The maximum frequency of ADRs was seen with Zidovudine + Lamivudine + Nevirapine (70.27%) combination followed by Stavudine + Lamivudine + Nevirapine (21.62%) and Stavudine + Lamivudine + Efavirenz (8.10%). Anemia and gastritis (12% each) were most common ADRs followed by vomiting (11.7%) and rash (10.8%). Most of the adverse drug events (ADE) were of type A (83.78%). The severity of most of the ADR events was mild (70.27%), followed by moderate (27.02%) and severe (1.78%).

Conclusion: ADRs are common with HAART. Maximum number of ADRs occurred in females and Zidovudine + Lamivudine + Nevirapine (70.27%) combination was the main culprit. To minimize the potential risks of ADR due to ART, the clinicians need to detect them earlier and prevent them whenever possible and choose drugs with safer adverse drug profile.

Key words: ADRs; Adverse drug events; Anti-retroviral therapy; HAART; HIV

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Shamiya Sadiq Articles by Sapna Gupta Articles by Vijay Khajuria Articles by Vishal R Tandon Articles by Annil Mahajan Articles by Mrityunjay Gupta
	on Google
	on Google Scholar

REFERENCES

1. UNAIDS Report on Global AIDS Epidemic 2013. Available at: http://www.unaids.org/globalreport/Global_report_2013_en_pdf [accessed Dec 16, 2015].

2. Cesar C, Shepherd BE, Krollewiecki AJ, Fink VI, Schechter M, Tuboi SH, et al. Rates and reasons for early change of first HAART in HIV-1-infected in 7 sites throughout the Caribbean and Latin America. PLoS One. 2010;5(1):10490. [DOI via Crossref] [Pubmed] [PMC Free Fulltext]

3. Fangel SJ. The effectiveness of highly active antiretroviral therapy in HIV-infected patients. Dan Med Bull. 2004;51:371-92.

4. Fellay J, Boubaker K, Ledergerber B, Bernasconi E, Furrer H, Battegay M, et al. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV cohort study. Lancet. 2001;358(9290):1322-7. [DOI via Crossref]

5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45. [DOI via Crossref] [Pubmed]

6. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229-32. [Pubmed]

7. Rawlins MD, Thompson JW. Mechanism of adverse drug reaction. In: Davies DM (Ed.), Textbook of Adverse Drug Reactions, 4th edn. Oxford: Oxford Medical Publication, 1991.

8. Srikanth BA, Babu SC, Yadav HN, Jain SK. Incidence of adverse drug reactions in human immune deficiency virus-positive patients using highly active antiretroviral therapy. J Adv Pharm Technol Res. 2012;3(1):62-7. [Pubmed] [PMC Free Fulltext]

9. Lartey M, Quashie AA, Essel A, Kenu E, Ganu V, Neequaye A. Adverse drug reactions to antiretroviral therapy during the early art period at a tertiary hospital in Ghana. Pan Afr Med J. 2014;18:25. [DOI via Crossref] [Pubmed] [PMC Free Fulltext]

10. Jha AK, Gadgade A, Shenoy AK, Chowta MN, Ramapuram JT. Evaluation of adverse drug reaction in HIV positive patients in a tertiary care hospital. Perspect Clin Res. 2015;6(1):34-6. [DOI via Crossref] [Pubmed] [PMC Free Fulltext]

11. Maniar NG, Desai S. Antiretroviral therapy: real challenges for developing world. AIDS. 2000;14(4):86.

12. Millogo A, Lankoande D, Yameogo I, YamÃ©ogo AA, Sawadogo AB. Polyneuropathies in patients treated with HAART in BoboDioulasso hospital, Burkina Faso. Bull Soc Pathol Exot. 2008; 101:11-3. [Pubmed]

13. Montessori V, Press N, Harris M, Akagi L, Montaner JSG. Adverse effects of antiretroviral therapy for HIV infection. CMAJ. 2004; 170(2). [Pubmed] [PMC Free Fulltext]

14. Nadkar MY, Bajpai S. Antiretroviral therapy: toxicity and adherence. J Assoc Physicians India. 2009;57(5):375-6. [Pubmed]

15. Ogundahunsi OA, Oyegungle VA, Ogun SA, Odusoga OL, Daniel OJ. HAART and lipid metabolism in a resource poor West African setting. Afr J Biomed Res. 2008;11:27-31.

16. Patel AK, Pujari S, Patel K, Patel J, Shah N, Patel B, et al. Nevirapine versus efavirenz based antiretroviral treatment in naÃ¯ve Indian patients: comparison of effectiveness in clinical cohort. JAPI. 2006;54:915-8. [Pubmed]

17. Salami AK, Olatunji PO, Fawibe EA, Oluboyo PO. Influence of highly active antiretroviral therapy (HAART) on the survival of HIVinfected patients: part report of the ilorin trial centre. Afr J Clin Experimen Microbiol. 2005;6:34-9.

18. Sharma A, Vora R, Modi M, Sharma A, Marfati Y. Adverse effects of antiretroviral treatment. Indian J Dermatol Venereol Leprol. 2008;74(3):234-7. [DOI via Crossref] [Pubmed]

19. Singh H, Dulhani N, Tiwari P, Singh P, Sinha T. A prospective, observational cohort study to elicit adverse effects of antiretroviral agents in a remote resource-restricted tribal population of Chhattisgarh. Indian J Pharmacol. 2009;41(5):224-6. [DOI via Crossref] [Pubmed] [PMC Free Fulltext]

20. Seth P. The situation of HIV/M.tuberculosis co-infection in India. Open Infect Dis J. 2011;5(1-5):51-9. [DOI via Crossref]

21. Heil EL, Townsend ML, Shipp K, Clarke A, Johnson MD. Incidence of severe hepatotoxicity related to antiretroviral therapy in HIV/HCV coinfected patients. AIDS Res Treat 2010; article ID 856542. [DOI via Crossref] [Pubmed] [PMC Free Fulltext]

22. Reliquet V, Mussini JM, Chennebault JM, Lafeuillade A, Raffi F. Peripheral neuropathy during Stavudine-Didanosine antiretroviral therapy. HIV Med. 2001;2(2):92-6. [DOI via Crossref] [Pubmed]

23. Radhakrishnan R, Vidyasagar S, Varma M, Naik A, Hegde MB, Guddattu V, Kamath A. Pattern of use of highly active antiretroviral therapy regimens and pattern of occurrence of adverse drug reactions in an Indian human immunodeficiency virus positive patients. Clin Res HIV Aids Prevention. 2013;1(3):1-12.

24. Reddy AVK, Lihite RJ, Lahkar M, Choudhury U, Baruah SK. A study on adverse drug reactions in HIV infected patients at a art centre of tertiary care hospital in Guwahati, India. Asian J Pharm Clin Res. 2013;6(2):102-4.

This Article Cited By the following articles

PHARMACOEPIDEMIOLOGICAL EVALUATION OF HIV PHARMACOTHERAPY AT DISTRICT ART CENTER IN SOUTH TELANGANA Asian J Pharm Clin Res 2022; (): 56.	1

Treatment outcome of different antiretroviral drug regimens in HIV-positive pregnant women Perspect Clin Res 2021; 12(1): 40.	2

How to Cite this Article

Pubmed Style

Shamiya Sadiq, Sapna Gupta, Vijay Khajuria, Vishal R Tandon, Annil Mahajan, Mrityunjay Gupta. Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution. Natl J Physiol Pharm Pharmacol. 2016; 6(3): 205-208. doi:10.5455/njppp.2016.6.31012016114

Web Style

Shamiya Sadiq, Sapna Gupta, Vijay Khajuria, Vishal R Tandon, Annil Mahajan, Mrityunjay Gupta. Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution. https://www.njppp.com/?mno=217023 [Access: June 02, 2022]. doi:10.5455/njppp.2016.6.31012016114

AMA (American Medical Association) Style

Shamiya Sadiq, Sapna Gupta, Vijay Khajuria, Vishal R Tandon, Annil Mahajan, Mrityunjay Gupta. Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution. Natl J Physiol Pharm Pharmacol. 2016; 6(3): 205-208. doi:10.5455/njppp.2016.6.31012016114

Vancouver/ICMJE Style

Shamiya Sadiq, Sapna Gupta, Vijay Khajuria, Vishal R Tandon, Annil Mahajan, Mrityunjay Gupta. Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution. Natl J Physiol Pharm Pharmacol. (2016), [cited June 02, 2022]; 6(3): 205-208. doi:10.5455/njppp.2016.6.31012016114

Harvard Style

Shamiya Sadiq, Sapna Gupta, Vijay Khajuria, Vishal R Tandon, Annil Mahajan, Mrityunjay Gupta (2016) Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution. Natl J Physiol Pharm Pharmacol, 6 (3), 205-208. doi:10.5455/njppp.2016.6.31012016114

Turabian Style

Shamiya Sadiq, Sapna Gupta, Vijay Khajuria, Vishal R Tandon, Annil Mahajan, Mrityunjay Gupta. 2016. Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution. National Journal of Physiology, Pharmacy and Pharmacology, 6 (3), 205-208. doi:10.5455/njppp.2016.6.31012016114

Chicago Style

Shamiya Sadiq, Sapna Gupta, Vijay Khajuria, Vishal R Tandon, Annil Mahajan, Mrityunjay Gupta. "Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution." National Journal of Physiology, Pharmacy and Pharmacology 6 (2016), 205-208. doi:10.5455/njppp.2016.6.31012016114

MLA (The Modern Language Association) Style

Shamiya Sadiq, Sapna Gupta, Vijay Khajuria, Vishal R Tandon, Annil Mahajan, Mrityunjay Gupta. "Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution." National Journal of Physiology, Pharmacy and Pharmacology 6.3 (2016), 205-208. Print. doi:10.5455/njppp.2016.6.31012016114

APA (American Psychological Association) Style

Shamiya Sadiq, Sapna Gupta, Vijay Khajuria, Vishal R Tandon, Annil Mahajan, Mrityunjay Gupta (2016) Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution. National Journal of Physiology, Pharmacy and Pharmacology, 6 (3), 205-208. doi:10.5455/njppp.2016.6.31012016114



Copyright � 2022 National Journal of Physiology, Pharmacy and Pharmacology All Rights Reserved. Subject to change without notice from or liability to National Journal of Physiology, Pharmacy and Pharmacology. For best results, please use Internet Explorer or Google Chrome	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272

Contact Information

How to cite this article